All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Hepatitis C virus E2 (HCV-E2) is a viral structural protein found in the hepatitis C virus, which is present on the viral membrane and functions as a host receptor binding protein, mediating entry into host cells. HCV-E2 is associated with hepatocellular carcinoma, mixed cryoglobulinemia and B-cell lymphoma.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-MZ179 | Anti-HCV/E2 (e137) h(CD3ζ) CAR, pCDCAR1 | Human | e137 | Human | scFv-CD3ζ | Retroviral | T cell | ||
CAR-MZ180 | Anti-HCV/E2 (e137) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | e137 | Human | scFv-CD28-CD3ζ | Retroviral | T cell | ||
CAR-MZ181 | Anti-HCV/E2 (e137) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 | Human | e137 | Human | scFv-CD28-41BB-CD3ζ | Retroviral | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION